Edition:
United States

Spectrum Pharmaceuticals Inc (SPPI.OQ)

SPPI.OQ on NASDAQ Stock Exchange Global Select Market

6.57USD
4:00pm EDT
Change (% chg)

$-0.12 (-1.79%)
Prev Close
$6.69
Open
$6.69
Day's High
$6.75
Day's Low
$6.53
Volume
135,031
Avg. Vol
211,670
52-wk High
$7.73
52-wk Low
$3.21

Select another date:

Wed, Mar 8 2017

BRIEF-Spectrum Pharmaceuticals reports Q4 loss per share of $0.22

* Spectrum Pharmaceuticals reports fourth quarter 2016 and full year 2016 financial results and pipeline update

Spectrum Pharma says FDA rejects its bladder cancer drug

Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration had rejected the drugmaker's bladder cancer treatment, apaziquone.

UPDATE 1-Spectrum Pharma says U.S. FDA rejects its bladder cancer drug

Nov 18 Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration had rejected the drugmaker's bladder cancer treatment, apaziquone.

BRIEF-Spectrum Pharma receives complete response letter from FDA for Qapzola

* Spectrum Pharmaceuticals Inc says on November 15, 2016, company met with FDA to discuss strategy for further development of Qapzola

Spectrum Pharma says U.S. FDA rejects its bladder cancer drug

Nov 18 Spectrum Pharmaceuticals Inc said on Friday the U.S. Food and Drug Administration rejected the drugmaker's bladder cancer treatment.

BRIEF-Spectrum pharmaceuticals posts Q3 loss per share of $0.22

* Spectrum Pharmaceuticals Inc says total product sales were $30.3 million in Q3 of 2016

Select another date:

More From Around the Web